

16–17 September 2026 · Baltimore, Maryland, USA
Exploring how sex differences shape immunity across the first 1,000 days of life
This September, Prof Veron Ramsuran will travel to Johns Hopkins University to participate in the Immune Development in Early Life (IDEaL) Annual Meeting, taking place from 16–17 September 2026. The two-day meeting will bring together researchers from leading institutions to explore how the immune system develops during the earliest stages of life and how these early processes can shape health across childhood and beyond.
The programme spans a wide range of research in early-life immunity, from vaccine responses and respiratory infections to T-cell development, immune regulation and multi-omics. Researchers from institutions including Johns Hopkins University, Harvard Medical School, Yale University, Columbia University and others will contribute to discussions around some of the most important questions in childhood immune development.
Meeting Details
The Presentation · Day Two
“Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence”
Prof Veron Ramsuran (University of KwaZulu-Natal) & Prof Philip Goulder (University of Oxford)
Their presentation will examine differences in immune responses between males and females and how these differences emerge and evolve during critical stages of early development. The first 1,000 days of life represent an important period of growth and immune development, and exploring how biological sex influences immunity during this period, and how these differences continue through childhood and adolescence, can provide important insight into why immune responses and disease outcomes may differ between individuals.
Prof Ramsuran’s participation in the IDEaL Annual Meeting provides an opportunity to contribute research from South Africa and the University of KwaZulu-Natal to a broader international discussion on early-life immunity. It also creates a valuable platform for scientific exchange with researchers working across immunology, infectious diseases and childhood health, while strengthening connections that can support future research and collaboration.
